Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 460

1.

Headspace GC/MS Analysis of Residual Solvents in Dietary Supplements, Cosmetics, and Household Products Using Ethyl Lactate as a Dissolution Medium.

Sugaya N, Takahashi M, Sakurai K, Tahara M, Kawakami T.

J AOAC Int. 2019 Sep 11. doi: 10.5740/jaoacint.19-0260. [Epub ahead of print]

PMID:
31511126
2.

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions.

Guigay J, Tahara M, Licitra L, Keilholz U, Friesland S, Witzler P, Mesía R.

Front Oncol. 2019 Aug 21;9:668. doi: 10.3389/fonc.2019.00668. eCollection 2019. Review.

3.

Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial.

Haddad R, Guigay J, Keilholz U, Clement PM, Fayette J, de Souza Viana L, Rolland F, Cupissol D, Geoffrois L, Kornek G, Licitra L, Melichar B, Ribaldo Nicolau U, Rauch D, Zanetta-Devauges S, Cohen EEW, Machiels JP, Tahara M, Vermorken J, Geng Y, Zografos E, Gauler T.

Oral Oncol. 2019 Aug 23;97:82-91. doi: 10.1016/j.oraloncology.2019.08.004. [Epub ahead of print]

PMID:
31450171
4.

Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy.

Tahara M, Oda K, Yamasaki K, Kawaguchi T, Sennari K, Noguchi S, Sakamoto N, Kawanami T, Mukae H, Yatera K.

BMC Pulm Med. 2019 Aug 22;19(1):157. doi: 10.1186/s12890-019-0918-3.

5.

Relationship between the ablation index, lesion formation, and incidence of steam pops.

Mori H, Kato R, Sumitomo N, Ikeda Y, Goto K, Tanaka S, Asano S, Tahara M, Nagase T, Iwanaga S, Muramatsu T, Matsumoto K.

J Arrhythm. 2019 Jun 1;35(4):636-644. doi: 10.1002/joa3.12195. eCollection 2019 Aug.

6.

Development of molecular markers associated with resistance to Meloidogyne incognita by performing quantitative trait locus analysis and genome-wide association study in sweetpotato.

Sasai R, Tabuchi H, Shirasawa K, Kishimoto K, Sato S, Okada Y, Kuramoto A, Kobayashi A, Isobe S, Tahara M, Monden Y.

DNA Res. 2019 Aug 3. pii: dsz018. doi: 10.1093/dnares/dsz018. [Epub ahead of print]

PMID:
31377774
7.

Genome-Wide Association Studies (GWAS) for Yield and Weevil Resistance in Sweet potato (Ipomoea batatas (L.) Lam).

Okada Y, Monden Y, Nokihara K, Shirasawa K, Isobe S, Tahara M.

Plant Cell Rep. 2019 Jul 24. doi: 10.1007/s00299-019-02445-7. [Epub ahead of print]

PMID:
31342081
8.

[A Case of Left Upper Lobe Lung Cancer Successfully Diagnosed by Transesophageal Endoscopic Ultrasound with Bronchoscope-Guided Fine Needle Aspiration Alone].

Nemoto K, Uchimura K, Hara S, Chiba Y, Isoshima Y, Ohira H, Higashi Y, Tahara M, Uyama K, Tachiwada T, Noguchi S, Yamasaki K, Kawanami T, Yatera K.

J UOEH. 2019;41(2):243-248. doi: 10.7888/juoeh.41.243. Japanese.

9.

[Evaluation of the Influence of the Experience and Training of EBUS-TBNA on Diagnostic Rate and Safety].

Nakamura M, Uchimura K, Hara S, Ohira H, Chiba Y, Nemoto K, Higashi Y, Tahara M, Ikegami H, Hirano Y, Sakagami K, Uyama K, Sennari K, Tachiwada T, Kawabata H, Noguchi S, Yamasaki K, Kawanami T, Yatera K.

J UOEH. 2019;41(2):179-184. doi: 10.7888/juoeh.41.179. Japanese.

10.

Postoperative atrial fibrillation is associated with delayed early rehabilitation after heart valve surgery: a multicenter study.

Kato M, Saitoh M, Kawamura T, Iwata K, Sakurada K, Okamura D, Tahara M, Yuguchi S, Kamisaka K, Oura K, Mori Y, Morisawa T, Takahashi T.

Phys Ther Res. 2019 Mar 11;22(1):1-8. doi: 10.1298/ptr.E9957. eCollection 2019.

11.

Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus.

Tadokoro T, Jahan ML, Ito Y, Tahara M, Chen S, Imai A, Sugimura N, Yoshida K, Saito M, Ose T, Hashiguchi T, Takeda M, Fukuhara H, Maenaka K.

FEBS J. 2019 Jul 9. doi: 10.1111/febs.14991. [Epub ahead of print]

PMID:
31287622
12.

Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

Haddad R, Concha-Benavente F, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Kasper S, Vokes EE, Worden F, Saba NF, Tahara M, Jayaprakash V, Lynch M, Li L, Gillison ML, Harrington KJ, Ferris RL.

Cancer. 2019 Sep 15;125(18):3208-3218. doi: 10.1002/cncr.32190. Epub 2019 Jun 27.

13.

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.

Ferris RL, Licitra L, Fayette J, Even C, Blumenschein G Jr, Harrington KJ, Guigay J, Vokes EE, Saba NF, Haddad R, Ramkumar S, Russell J, Brossart P, Tahara M, Colevas AD, Concha-Benavente F, Lynch M, Li L, Gillison ML.

Clin Cancer Res. 2019 Sep 1;25(17):5221-5230. doi: 10.1158/1078-0432.CCR-18-3944. Epub 2019 Jun 25.

PMID:
31239321
14.

Factors related to physical functioning decline after cardiac surgery in older patients: A multicenter retrospective study.

Itagaki A, Saitoh M, Okamura D, Kawamura T, Otsuka S, Tahara M, Mori Y, Kamisaka K, Ochi Y, Yuguchi S, Kato M, Morisawa T, Takahashi T.

J Cardiol. 2019 Sep;74(3):279-283. doi: 10.1016/j.jjcc.2019.02.020. Epub 2019 Jun 20.

PMID:
31230900
15.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
16.

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).

Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.

Jpn J Clin Oncol. 2019 Jul 1;49(7):589-595. doi: 10.1093/jjco/hyz052.

PMID:
31194232
17.

[The Concept of Platinum-Resistance and Treatment Strategies in Head and Neck Cancer].

Tahara M.

Gan To Kagaku Ryoho. 2019 May;46(5):885-890. Japanese.

PMID:
31189809
18.

Fatal Acute Exacerbation of Familial Interstitial Pneumonia Complicated with Dyskeratosis Congenita after Influenza Virus B Infection.

Tachiwada T, Oda K, Tahara M, Sennari K, Nemoto K, Noguchi S, Kawanami T, Kido T, Yamaguchi H, Yatera K.

Intern Med. 2019 Sep 15;58(18):2683-2687. doi: 10.2169/internalmedicine.2413-18. Epub 2019 Jun 7.

19.

Predominant Detection of the Subgroup A2b Human Metapneumovirus Strain with a 111-Nucleotide Duplication in the G gene in Yokohama City, Japan in 2018.

Saikusa M, Nao N, Kawakami C, Usuku S, Tanaka N, Tahara M, Takeda M, Okubo I.

Jpn J Infect Dis. 2019 Sep 19;72(5):350-352. doi: 10.7883/yoken.JJID.2019.124. Epub 2019 May 31.

20.

Photocontrollable mononegaviruses.

Tahara M, Takishima Y, Miyamoto S, Nakatsu Y, Someya K, Sato M, Tani K, Takeda M.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11587-11589. doi: 10.1073/pnas.1906531116. Epub 2019 May 28.

21.

Impact of preoperative frailty on regaining walking ability in patients after cardiac surgery: Multicenter cohort study in Japan.

Yuguchi S, Saitoh M, Oura K, Tahara M, Kamisaka K, Kawamura T, Kato M, Morisawa T, Takahashi T.

Arch Gerontol Geriatr. 2019 Jul - Aug;83:204-210. doi: 10.1016/j.archger.2019.04.003. Epub 2019 Apr 8.

PMID:
31082565
22.

Consensus and variations in cell line specificity among human metapneumovirus strains.

Nao N, Sato K, Yamagishi J, Tahara M, Nakatsu Y, Seki F, Katoh H, Ohnuma A, Shirogane Y, Hayashi M, Suzuki T, Kikuta H, Nishimura H, Takeda M.

PLoS One. 2019 Apr 23;14(4):e0215822. doi: 10.1371/journal.pone.0215822. eCollection 2019.

23.

[A Case of Drug-Induced Lung Injury Caused by Kamikihito].

Tahara M, Yamasaki K, Ikegami H, Fukuda Y, Uchimura K, Tachiwada T, Noguchi S, Kawanami T, Kido T, Mukae H, Yatera K.

J UOEH. 2019;41(1):51-56. doi: 10.7888/juoeh.41.51. Japanese.

24.

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.

Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Adelstein D, Van Gestel D, Vermorken JB.

Front Oncol. 2019 Feb 21;9:86. doi: 10.3389/fonc.2019.00086. eCollection 2019. Review.

25.

Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.

Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M.

Int J Clin Oncol. 2019 Jul;24(7):789-797. doi: 10.1007/s10147-019-01418-w. Epub 2019 Feb 22.

PMID:
30796560
26.

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study).

Zenda S, Ota Y, Kiyota N, Okano S, Fujii M, Kitamura M, Takahashi S, Ueda T, Monden N, Yamanaka T, Tahara M.

Front Oncol. 2019 Jan 22;9:6. doi: 10.3389/fonc.2019.00006. eCollection 2019.

27.

Hard Metal Lung Disease with Favorable Response to Corticosteroid Treatment: A Case Report and Literature Review.

Chiba Y, Kido T, Tahara M, Oda K, Noguchi S, Kawanami T, Yokoyama M, Yatera K.

Tohoku J Exp Med. 2019 Jan;247(1):51-58. doi: 10.1620/tjem.247.51. Review.

28.

A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.

Takahashi S, Kiyota N, Yamazaki T, Chayahara N, Nakano K, Inagaki L, Toda K, Enokida T, Minami H, Imamura Y, Fukuda N, Sasaki T, Suzuki T, Ikezawa H, Dutcus CE, Tahara M.

Future Oncol. 2019 Mar;15(7):717-726. doi: 10.2217/fon-2018-0557. Epub 2019 Jan 14.

29.

Correlation between changes in functional connectivity in the dorsal attention network and the after-effects induced by prism adaptation in healthy humans: A dataset of resting-state fMRI and pointing after prism adaptation.

Tsujimoto K, Mizuno K, Nishida D, Tahara M, Yamada E, Shindo S, Watanabe Y, Kasuga S, Liu M.

Data Brief. 2018 Dec 18;22:583-589. doi: 10.1016/j.dib.2018.12.053. eCollection 2019 Feb.

30.

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK.

Uozumi S, Enokida T, Suzuki S, Nishizawa A, Kamata H, Okano T, Fujisawa T, Ueda Y, Okano S, Tahara M, Yamaguchi M.

Front Oncol. 2018 Dec 13;8:616. doi: 10.3389/fonc.2018.00616. eCollection 2018.

31.

[I. Genomic Medicine in Thyroid Cancer].

Enokida T, Tahara M.

Gan To Kagaku Ryoho. 2018 Dec;45(12):1711-1715. Japanese. No abstract available.

PMID:
30587725
32.

Prism adaptation changes resting-state functional connectivity in the dorsal stream of visual attention networks in healthy adults: A fMRI study.

Tsujimoto K, Mizuno K, Nishida D, Tahara M, Yamada E, Shindo S, Kasuga S, Liu M.

Cortex. 2018 Oct 31. pii: S0010-9452(18)30351-4. doi: 10.1016/j.cortex.2018.10.018. [Epub ahead of print]

PMID:
30471844
33.

Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine-refractory differentiated thyroid cancer.

Tahara M, Brose MS, Wirth LJ, Suzuki T, Miyagishi H, Fujino K, Dutcus CE, Gianoukakis A.

Eur J Cancer. 2019 Jan;106:61-68. doi: 10.1016/j.ejca.2018.10.002. Epub 2018 Nov 22.

34.

Brillouin characterization of slimmed polymer optical fibers for strain sensing with extremely wide dynamic range.

Mizuno Y, Matsutani N, Hayashi N, Lee H, Tahara M, Hosoda H, Nakamura K.

Opt Express. 2018 Oct 15;26(21):28030-28037. doi: 10.1364/OE.26.028030.

PMID:
30469859
35.

Usefulness of diluted contrast medium for test-scanning of infants scheduled for contrast-enhanced cardiovascular computed tomography angiography.

Masuda T, Funama Y, Nakaura T, Sato T, Tahara M, Matsumoto Y, Imada N, Miyazaki O, Awai K.

Br J Radiol. 2019 Feb;92(1094):20180572. doi: 10.1259/bjr.20180572. Epub 2018 Nov 14.

PMID:
30412445
36.

Cohort study exploring the effect of lenvatinib on differentiated thyroid cancer.

Tahara M, Takami H, Ito Y, Sugino K, Takahashi S, Takeyama H, Tsutsui H, Hara H, Mitsuma A, Yamashita H, Okamoto T, Sugitani I, Ohashi Y, Imai T.

Endocr J. 2018 Nov 29;65(11):1071-1074. doi: 10.1507/endocrj.EJ18-0261. Epub 2018 Oct 24.

37.

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).

Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group.

Jpn J Clin Oncol. 2019 Jan 1;49(1):37-41. doi: 10.1093/jjco/hyy145.

PMID:
30364985
38.

Optimal management of patients with hepatocellular carcinoma treated with lenvatinib.

Ikeda M, Kobayashi M, Tahara M, Kaneko S.

Expert Opin Drug Saf. 2018 Nov;17(11):1095-1105. doi: 10.1080/14740338.2018.1530212. Epub 2018 Oct 12. Review.

PMID:
30264594
39.

Age-dependent differences in response to partial-thickness cartilage defects in a rat model as a measure to evaluate the efficacy of interventions for cartilage repair.

Akatsu Y, Enomoto T, Yamaguchi S, Tahara M, Fukawa T, Endo J, Hoshi H, Yamamoto Y, Sasaki T, Takahashi K, Akagi R, Sasho T.

Cell Tissue Res. 2019 Feb;375(2):425-435. doi: 10.1007/s00441-018-2914-y. Epub 2018 Sep 26.

PMID:
30259137
40.

Radiation Dose Reduction With a Low-Tube Voltage Technique for Pediatric Chest Computed Tomographic Angiography Based on the Contrast-to-Noise Ratio Index.

Masuda T, Funama Y, Nakaura T, Tahara M, Yamashita Y, Kiguchi M, Imada N, Sato T, Awai K.

Can Assoc Radiol J. 2018 Nov;69(4):390-396. doi: 10.1016/j.carj.2018.05.004. Epub 2018 Sep 22.

PMID:
30249409
41.

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck.

Enokida T, Okano S, Fujisawa T, Ueda Y, Uozumi S, Tahara M.

Front Oncol. 2018 Aug 27;8:339. doi: 10.3389/fonc.2018.00339. eCollection 2018.

42.

Comparison of meniscal extrusion and osteophyte formation at the intercondylar notch as a predictive biomarker for incidence of knee osteoarthritis-Data from the Osteoarthritis Initiative.

Okada K, Yamaguchi S, Sato Y, Enomoto T, Ogawa Y, Ohtori S, Tahara M, Sasho T.

J Orthop Sci. 2019 Jan;24(1):121-127. doi: 10.1016/j.jos.2018.08.003. Epub 2018 Aug 28.

PMID:
30166083
43.

[SWEAT PLAYS A ROLE IN IMMUNE PROTECTION].

Murota H, Tahara M, Shindo S, Ono E, Yamaga K, Katayama I.

Arerugi. 2018;67(6):747-750. doi: 10.15036/arerugi.67.747. Japanese. No abstract available.

PMID:
30022783
44.

Four-directional approach to the meso-transverse attachment combined with preoperative radiological vascular simulation facilitates short-term surgical outcomes in laparoscopic transverse colon cancer surgery.

Koinuma K, Horie H, Ito H, Naoi D, Sadatomo A, Tahara M, Inoue Y, Kono Y, Sasaki T, Sugimoto H, Lefor AK, Sata N.

Asian J Endosc Surg. 2019 Apr;12(2):150-156. doi: 10.1111/ases.12628. Epub 2018 Jul 2.

PMID:
29963764
45.

Evaluating different closed loop graft preparation technique for tibial suspensory fixation in ACL reconstruction using TightRope™.

Sasho T, Sasaki T, Hoshi H, Akagi R, Enomoto T, Sato Y, Nakagawa R, Tahara M, Yamaguchi S.

Asia Pac J Sports Med Arthrosc Rehabil Technol. 2018 Mar 7;12:5-11. doi: 10.1016/j.asmart.2018.01.002. eCollection 2018 Apr.

46.

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.

Mehra R, Seiwert TY, Gupta S, Weiss J, Gluck I, Eder JP, Burtness B, Tahara M, Keam B, Kang H, Muro K, Geva R, Chung HC, Lin CC, Aurora-Garg D, Ray A, Pathiraja K, Cheng J, Chow LQM, Haddad R.

Br J Cancer. 2018 Jul;119(2):153-159. doi: 10.1038/s41416-018-0131-9. Epub 2018 Jun 29.

47.

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML.

Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17.

48.

CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.

Gillison ML, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Li L, Ferris RL.

Oncologist. 2018 Sep;23(9):1079-1082. doi: 10.1634/theoncologist.2017-0674. Epub 2018 Jun 4.

49.

Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery.

Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H.

Ann Gastroenterol Surg. 2018 Mar 25;2(3):212-219. doi: 10.1002/ags3.12066. eCollection 2018 May.

50.

The influence of the electrodes spacing of a mapping catheter on the atrial voltage substrate map.

Mori H, Kato R, Ikeda Y, Goto K, Tanaka S, Asano S, Shiki Y, Nagase T, Tahara M, Iwanaga S, Muramatsu T, Matsumoto K.

J Cardiol. 2018 Nov;72(5):434-442. doi: 10.1016/j.jjcc.2018.04.012. Epub 2018 May 30.

PMID:
29859827

Supplemental Content

Loading ...
Support Center